Cargando…
The role of miR1 and miR133a in new-onset atrial fibrillation after acute myocardial infarction
BACKGROUND: The development of new-onset atrial fibrillation (NOAF) after acute myocardial infarction (AMI) is a clinical complication that requires a better understanding of the causative risk factors. This study aimed to explore the risk factors and the expression and function of miR-1 and miR-133...
Autores principales: | Zeng, Qingyi, Li, Wei, Luo, Zhenghua, Zhou, Haiyan, Duan, Zhonggang, Xiong, Xin Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496401/ https://www.ncbi.nlm.nih.gov/pubmed/37697243 http://dx.doi.org/10.1186/s12872-023-03462-x |
Ejemplares similares
-
Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction
por: Peng, Liu, et al.
Publicado: (2014) -
Upregulation of miR-133b and miR-328 in Patients With Atrial Dilatation: Implications for Stretch-Induced Atrial Fibrillation
por: Masè, Michela, et al.
Publicado: (2019) -
Role of miR-1 and miR-133a in myocardial ischemic postconditioning
por: He, Bin, et al.
Publicado: (2011) -
The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism
por: Chen, Yao-ping, et al.
Publicado: (2016) -
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
por: Koutsoulidou, Andrie, et al.
Publicado: (2011)